Skip to main content
Article thumbnail
Location of Repository

A critical role for OX40 in T cell-mediated immunopathology during lung viral infection

By Ian R. Humphreys, Gerhard Walzl, Tracy Hussell and Sue Hill

Abstract

Respiratory infections are the third leading cause of death worldwide. Illness is caused by pathogen replication and disruption of airway homeostasis by excessive expansion of cell numbers. One strategy to prevent lung immune–mediated damage involves reducing the cellular burden. To date, antiinflammatory strategies have affected both antigen-specific and naive immune repertoires. Here we report a novel form of immune intervention that specifically targets recently activated T cells alone. OX40 (CD134) is absent on naive T cells but up-regulated 1–2 d after antigen activation. OX40–immunoglobulin fusion proteins block the interaction of OX40 with its ligand on antigen-presenting cells and eliminate weight loss and cachexia without preventing virus clearance. Reduced proliferation and enhanced apoptosis of lung cells accompanied the improved clinical phenotype. Manipulation of this late costimulatory pathway has clear therapeutic potential for the treatment of dysregulated lung immune responses

Publisher: Rockefeller University Press
Year: 2003
OAI identifier: oai:http://orca.cf.ac.uk:252

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.